vs

Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.

GREENPOWER MOTOR Co INC. is the larger business by last-quarter revenue ($7.2M vs $4.9M, roughly 1.5× Sensus Healthcare, Inc.). Sensus Healthcare, Inc. runs the higher net margin — -64.1% vs -65.6%, a 1.5% gap on every dollar of revenue. On growth, GREENPOWER MOTOR Co INC. posted the faster year-over-year revenue change (-11.5% vs -62.2%).

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.

GP vs SRTS — Head-to-Head

Bigger by revenue
GP
GP
1.5× larger
GP
$7.2M
$4.9M
SRTS
Growing faster (revenue YoY)
GP
GP
+50.7% gap
GP
-11.5%
-62.2%
SRTS
Higher net margin
SRTS
SRTS
1.5% more per $
SRTS
-64.1%
-65.6%
GP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GP
GP
SRTS
SRTS
Revenue
$7.2M
$4.9M
Net Profit
$-4.7M
$-3.2M
Gross Margin
14.6%
38.4%
Operating Margin
-63.8%
Net Margin
-65.6%
-64.1%
Revenue YoY
-11.5%
-62.2%
Net Profit YoY
-2.1%
-304.9%
EPS (diluted)
$-0.17
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GP
GP
SRTS
SRTS
Q4 25
$4.9M
Q3 25
$6.9M
Q2 25
$7.3M
Q1 25
$8.3M
Q4 24
$7.2M
$13.1M
Q3 24
$5.3M
$8.8M
Q2 24
$3.0M
$9.2M
Q1 24
$10.7M
Net Profit
GP
GP
SRTS
SRTS
Q4 25
$-3.2M
Q3 25
$-943.0K
Q2 25
$-1.0M
Q1 25
$-2.6M
Q4 24
$-4.7M
$1.5M
Q3 24
$-4.7M
$1.2M
Q2 24
$-5.4M
$1.6M
Q1 24
$2.3M
Gross Margin
GP
GP
SRTS
SRTS
Q4 25
38.4%
Q3 25
39.4%
Q2 25
39.7%
Q1 25
52.2%
Q4 24
14.6%
54.4%
Q3 24
8.6%
59.3%
Q2 24
7.4%
58.7%
Q1 24
62.5%
Operating Margin
GP
GP
SRTS
SRTS
Q4 25
-63.8%
Q3 25
-37.3%
Q2 25
-26.6%
Q1 25
-31.7%
Q4 24
13.2%
Q3 24
16.9%
Q2 24
21.5%
Q1 24
27.1%
Net Margin
GP
GP
SRTS
SRTS
Q4 25
-64.1%
Q3 25
-13.7%
Q2 25
-14.2%
Q1 25
-30.8%
Q4 24
-65.6%
11.8%
Q3 24
-87.9%
13.7%
Q2 24
-179.8%
17.4%
Q1 24
21.3%
EPS (diluted)
GP
GP
SRTS
SRTS
Q4 25
$-0.19
Q3 25
$-0.06
Q2 25
$-0.06
Q1 25
$-0.16
Q4 24
$-0.17
$0.10
Q3 24
$-0.18
$0.07
Q2 24
$-0.21
$0.10
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GP
GP
SRTS
SRTS
Cash + ST InvestmentsLiquidity on hand
$621.1K
$22.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.1M
$48.1M
Total Assets
$37.4M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GP
GP
SRTS
SRTS
Q4 25
$22.1M
Q3 25
$24.5M
Q2 25
$22.2M
Q1 25
$19.1M
Q4 24
$621.1K
$22.1M
Q3 24
$116.9K
$22.6M
Q2 24
$528.3K
$19.0M
Q1 24
$14.7M
Stockholders' Equity
GP
GP
SRTS
SRTS
Q4 25
$48.1M
Q3 25
$51.2M
Q2 25
$52.1M
Q1 25
$53.0M
Q4 24
$2.1M
$55.8M
Q3 24
$4.2M
$54.1M
Q2 24
$8.6M
$52.9M
Q1 24
$51.2M
Total Assets
GP
GP
SRTS
SRTS
Q4 25
$53.0M
Q3 25
$58.3M
Q2 25
$58.9M
Q1 25
$60.2M
Q4 24
$37.4M
$62.2M
Q3 24
$39.4M
$59.9M
Q2 24
$43.5M
$58.2M
Q1 24
$57.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GP
GP
SRTS
SRTS
Operating Cash FlowLast quarter
$-1.1M
$-2.2M
Free Cash FlowOCF − Capex
$-2.4M
FCF MarginFCF / Revenue
-47.9%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$332.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GP
GP
SRTS
SRTS
Q4 25
$-2.2M
Q3 25
$2.3M
Q2 25
$3.1M
Q1 25
$-2.7M
Q4 24
$-1.1M
$-827.0K
Q3 24
$-1.3M
$4.0M
Q2 24
$-3.2M
$4.2M
Q1 24
$-8.2M
Free Cash Flow
GP
GP
SRTS
SRTS
Q4 25
$-2.4M
Q3 25
$2.3M
Q2 25
$3.1M
Q1 25
$-2.7M
Q4 24
$-1.1M
Q3 24
$3.6M
Q2 24
$4.2M
Q1 24
$-8.4M
FCF Margin
GP
GP
SRTS
SRTS
Q4 25
-47.9%
Q3 25
33.3%
Q2 25
42.2%
Q1 25
-32.2%
Q4 24
-8.6%
Q3 24
40.9%
Q2 24
45.8%
Q1 24
-79.0%
Capex Intensity
GP
GP
SRTS
SRTS
Q4 25
3.2%
Q3 25
0.1%
Q2 25
0.4%
Q1 25
0.1%
Q4 24
2.3%
Q3 24
3.8%
Q2 24
0.0%
Q1 24
2.2%
Cash Conversion
GP
GP
SRTS
SRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.53×
Q3 24
3.25×
Q2 24
2.62×
Q1 24
-3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GP
GP

Segment breakdown not available.

SRTS
SRTS

Products$2.8M57%
Other$2.1M43%

Related Comparisons